Lillian Smith is VP, Corporate Counsel of Allogene Therapeutics, Inc.. Currently has a direct ownership of 140,390 shares of ALLO, which is worth approximately $262,529. The most recent transaction as insider was on Apr 01, 2023, when has been sold 56,545 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 140K
0% 3M change
0% 12M change
Total Value Held $262,529

Lillian Smith Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 01 2023
BUY
Grant, award, or other acquisition
-
56,545 Added 28.71%
140,390 Common Stock
LS

Lillian Smith

VP, Corporate Counsel
South San Francisco, CA

Track Institutional and Insider Activities on ALLO

Follow Allogene Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALLO shares.

Notify only if

Insider Trading

Get notified when an Allogene Therapeutics, Inc. insider buys or sells ALLO shares.

Notify only if

News

Receive news related to Allogene Therapeutics, Inc.

Track Activities on ALLO